160 related articles for article (PubMed ID: 38605214)
1. LPCAT2 inhibits colorectal cancer progression via the PRMT1/SLC7A11 axis.
Cao N; Zhang F; Yin J; Zhang J; Bian X; Zheng G; Li N; Lin Y; Luo L
Oncogene; 2024 May; 43(22):1714-1725. PubMed ID: 38605214
[TBL] [Abstract][Full Text] [Related]
2. PRMT1-mediated H4R3me2a recruits SMARCA4 to promote colorectal cancer progression by enhancing EGFR signaling.
Yao B; Gui T; Zeng X; Deng Y; Wang Z; Wang Y; Yang D; Li Q; Xu P; Hu R; Li X; Chen B; Wang J; Zen K; Li H; Davis MJ; Herold MJ; Pan HF; Jiang ZW; Huang DCS; Liu M; Ju J; Zhao Q
Genome Med; 2021 Apr; 13(1):58. PubMed ID: 33853662
[TBL] [Abstract][Full Text] [Related]
3. CircRNA circSTIL inhibits ferroptosis in colorectal cancer via miR-431/SLC7A11 axis.
Li Q; Li K; Guo Q; Yang T
Environ Toxicol; 2023 May; 38(5):981-989. PubMed ID: 36840697
[TBL] [Abstract][Full Text] [Related]
4. E3 ubiquitin ligase HECTD3 is a tumor suppressor and mediates the polyubiquitination of SLC7A11 to promote ferroptosis in colon cancer.
Huang F; Huang Z; Wei Q; Liu G; Pu J
Exp Cell Res; 2023 Sep; 430(1):113697. PubMed ID: 37422058
[TBL] [Abstract][Full Text] [Related]
5. PRMT1 enhances oncogenic arginine methylation of NONO in colorectal cancer.
Yin XK; Wang YL; Wang F; Feng WX; Bai SM; Zhao WW; Feng LL; Wei MB; Qin CL; Wang F; Chen ZL; Yi HJ; Huang Y; Xie PY; Kim T; Wang YN; Hou JW; Li CW; Liu Q; Fan XJ; Hung MC; Wan XB
Oncogene; 2021 Feb; 40(7):1375-1389. PubMed ID: 33420374
[TBL] [Abstract][Full Text] [Related]
6. Targeting SLC7A11 specifically suppresses the progression of colorectal cancer stem cells via inducing ferroptosis.
Xu X; Zhang X; Wei C; Zheng D; Lu X; Yang Y; Luo A; Zhang K; Duan X; Wang Y
Eur J Pharm Sci; 2020 Sep; 152():105450. PubMed ID: 32621966
[TBL] [Abstract][Full Text] [Related]
7. PRMT1 inhibition promotes ferroptosis sensitivity via ACSL1 upregulation in acute myeloid leukemia.
Zhou L; Jia X; Shang Y; Sun Y; Liu Z; Liu J; Jiang W; Deng S; Yao Q; Chen J; Li H
Mol Carcinog; 2023 Aug; 62(8):1119-1135. PubMed ID: 37144835
[TBL] [Abstract][Full Text] [Related]
8. miR-509-5p promotes colorectal cancer cell ferroptosis by targeting SLC7A11.
Elrebehy MA; Abdelghany TM; Elshafey MM; Gomaa MH; Doghish AS
Pathol Res Pract; 2023 Jul; 247():154557. PubMed ID: 37229918
[TBL] [Abstract][Full Text] [Related]
9. PRMT1-mediated PGK1 arginine methylation promotes colorectal cancer glycolysis and tumorigenesis.
Liu H; Chen X; Wang P; Chen M; Deng C; Qian X; Bai J; Li Z; Yu X
Cell Death Dis; 2024 Feb; 15(2):170. PubMed ID: 38402202
[TBL] [Abstract][Full Text] [Related]
10. The dual function of PRMT1 in modulating epithelial-mesenchymal transition and cellular senescence in breast cancer cells through regulation of ZEB1.
Gao Y; Zhao Y; Zhang J; Lu Y; Liu X; Geng P; Huang B; Zhang Y; Lu J
Sci Rep; 2016 Jan; 6():19874. PubMed ID: 26813495
[TBL] [Abstract][Full Text] [Related]
11. Combinative treatment of β-elemene and cetuximab is sensitive to KRAS mutant colorectal cancer cells by inducing ferroptosis and inhibiting epithelial-mesenchymal transformation.
Chen P; Li X; Zhang R; Liu S; Xiang Y; Zhang M; Chen X; Pan T; Yan L; Feng J; Duan T; Wang D; Chen B; Jin T; Wang W; Chen L; Huang X; Zhang W; Sun Y; Li G; Kong L; Chen X; Li Y; Yang Z; Zhang Q; Zhuo L; Sui X; Xie T
Theranostics; 2020; 10(11):5107-5119. PubMed ID: 32308771
[No Abstract] [Full Text] [Related]
12. PRMT5 functionally associates with EZH2 to promote colorectal cancer progression through epigenetically repressing CDKN2B expression.
Yang L; Ma DW; Cao YP; Li DZ; Zhou X; Feng JF; Bao J
Theranostics; 2021; 11(8):3742-3759. PubMed ID: 33664859
[No Abstract] [Full Text] [Related]
13. SLC7A11 as a biomarker and therapeutic target in HPV-positive head and neck Squamous Cell Carcinoma.
Hémon A; Louandre C; Lailler C; Godin C; Bottelin M; Morel V; François C; Galmiche A; Saidak Z
Biochem Biophys Res Commun; 2020 Dec; 533(4):1083-1087. PubMed ID: 33019976
[TBL] [Abstract][Full Text] [Related]
14. Construction and Validation of Novel Ferroptosis-related Risk Score Signature and Prognostic Prediction Nomogram for Patients with Colorectal Cancer.
Liu R; Wang Y; Bu J; Li Q; Chen F; Zhu M; Chi H; Yu G; Zhu T; Zhu X; Zhao G
Int J Med Sci; 2024; 21(6):1103-1116. PubMed ID: 38774759
[No Abstract] [Full Text] [Related]
15. PRMT1 Is a Novel Regulator of Epithelial-Mesenchymal-Transition in Non-small Cell Lung Cancer.
Avasarala S; Van Scoyk M; Karuppusamy Rathinam MK; Zerayesus S; Zhao X; Zhang W; Pergande MR; Borgia JA; DeGregori J; Port JD; Winn RA; Bikkavilli RK
J Biol Chem; 2015 May; 290(21):13479-89. PubMed ID: 25847239
[TBL] [Abstract][Full Text] [Related]
16. Metformin induces Ferroptosis by inhibiting UFMylation of SLC7A11 in breast cancer.
Yang J; Zhou Y; Xie S; Wang J; Li Z; Chen L; Mao M; Chen C; Huang A; Chen Y; Zhang X; Khan NUH; Wang L; Zhou J
J Exp Clin Cancer Res; 2021 Jun; 40(1):206. PubMed ID: 34162423
[TBL] [Abstract][Full Text] [Related]
17. Brusatol hinders the progression of bladder cancer by Chac1/Nrf2/SLC7A11 pathway.
Yu X; He Z; Wang Z; Ke S; Wang H; Wang Q; Li S
Exp Cell Res; 2024 May; 438(2):114053. PubMed ID: 38663476
[TBL] [Abstract][Full Text] [Related]
18. The N6-methyladenosine modification enhances ferroptosis resistance through inhibiting SLC7A11 mRNA deadenylation in hepatoblastoma.
Liu L; He J; Sun G; Huang N; Bian Z; Xu C; Zhang Y; Cui Z; Xu W; Sun F; Zhuang C; Man Q; Gu S
Clin Transl Med; 2022 May; 12(5):e778. PubMed ID: 35522946
[TBL] [Abstract][Full Text] [Related]
19. Regulation of H2A ubiquitination and SLC7A11 expression by BAP1 and PRC1.
Zhang Y; Koppula P; Gan B
Cell Cycle; 2019 Apr; 18(8):773-783. PubMed ID: 30907299
[TBL] [Abstract][Full Text] [Related]
20. Methylation of C/EBPα by PRMT1 Inhibits Its Tumor-Suppressive Function in Breast Cancer.
Liu LM; Sun WZ; Fan XZ; Xu YL; Cheng MB; Zhang Y
Cancer Res; 2019 Jun; 79(11):2865-2877. PubMed ID: 31015230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
